Forbes August 11, 2022
Russell Flannery

Note: President Joe Biden in February launched a “Cancer Moonshot” initiative that aims to reduce the death rate from cancer by 50% in the next 25 years. This is a part of a series of posts with cancer experts offering suggestions to help the Moonshot succeed. The related, upcoming 3rd Forbes China Healthcare Summit” on August 27 (August 26 ET) will address “New International Directions For A Reignited Moonshot” as its main theme this year. Registration is free. For more information, please contact: julie.lu@forbeschina.com

BeiGene CEO and co-founder John V. Oyler made a mark in the international fight against cancer by leading the first company to have a drug developed in China obtain FDA approval — the anti-cancer drug, Brukinsa,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Congress / White House, Govt Agencies, Patient / Consumer, Provider
Related Articles:
50 things to know about HCA, Tenet, CHS and UHS
How the primary care shortage is spilling over into ASCs
Private equity bankruptcies in healthcare explode 112% in 5 years
How Mercy accelerated rare disease diagnoses in rural areas
Study: Disparities in access to in-network behavioral health care pervasive

Share This Article